FDA Warning Letter — Centaur Pharmaceuticals Private Ltd.

Case 655231 — FEI 3008861619

The FDA took a Warning Letter action against Centaur Pharmaceuticals Private Ltd. on July 25, 2023 (Pune, India). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Centaur Pharmaceuticals Private Ltd.
Date
July 25, 2023
Fiscal Year
2023
Product Type
Drugs
Center
CDER
Location
Pune (India)